Form 4: Calix Inc. Director Christopher J. Bowick Reports Stock Option Grant

Director Christopher J. Bowick reports the acquisition of stock options for Calix, Inc.

Summary

• Christopher J. Bowick, a director of Calix, Inc., filed a Form 4 on May 13, 2024, reporting a transaction.
• On May 9, 2024, Bowick acquired stock options to purchase 12,262 shares of Calix common stock at an exercise price of $30.07.
• The options vest on the earlier of May 9, 2025, or the day before the next annual meeting of stockholders following the grant year, and expire on May 9, 2034.
• Following the transaction, Bowick directly owns 12,262 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it is a standard disclosure of stock option grants, which is a common practice.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders, incentivizing them to work towards increasing the company's value.

Industry Context

Stock option grants are a common practice in the technology industry to incentivize and retain key personnel, aligning their interests with the long-term success of the company.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the tech industry, used by companies like Cisco, Juniper Networks, and Arista Networks to attract and retain talent.
• The vesting schedule of one year is fairly typical, aligning with industry norms for incentivizing long-term commitment.
• The exercise price is set at the market price on the grant date, which is standard practice.

Stakeholder Impact

• The stock option grant could have a slightly positive impact on shareholders as it incentivizes the director to work towards increasing the company's value.

Key Dates